Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -712.26%-35.11M | ---- | 79.94%-4.32M | ---- | -2,987.54%-21.55M | ---- | -103.78%-698K | ---- | -16.73%18.46M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -132.21%-757K | ---- | -515.09%-326K | ---- | -307.69%-53K | ---- | 90.08%-13K | ---- | 61.70%-131K |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | 17.63%19.61M | ---- | 158.92%16.67M | ---- | -6,756.71%-28.29M |
| Impairment and provisions: | ---- | -44.95%6.81M | ---- | 40.84%12.37M | ---- | -21.51%8.79M | ---- | 305.69%11.19M | ---- | 15.97%2.76M |
| -Impairment of trade receivables (reversal) | ---- | -35.30%7.23M | ---- | 332.33%11.17M | ---- | -74.68%2.58M | ---- | 287.54%10.2M | ---- | 11.48%2.63M |
| -Other impairments and provisions | ---- | -134.33%-414K | ---- | -80.55%1.21M | ---- | 524.57%6.2M | ---- | 681.89%993K | ---- | 605.56%127K |
| Revaluation surplus: | ---- | 175.85%7.53M | ---- | -11,304.60%-9.92M | ---- | -116.02%-87K | ---- | --543K | ---- | ---- |
| -Other fair value changes | ---- | 175.85%7.53M | ---- | -11,304.60%-9.92M | ---- | -116.02%-87K | ---- | --543K | ---- | ---- |
| Asset sale loss (gain): | ---- | ---314K | ---- | ---- | ---- | ---- | ---- | ---540K | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---314K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---540K | ---- | ---- |
| Depreciation and amortization: | ---- | -39.39%4.56M | ---- | 20.85%7.52M | ---- | -0.72%6.23M | ---- | -14.13%6.27M | ---- | -5.86%7.3M |
| Financial expense | ---- | 18.83%2.32M | ---- | -51.83%1.95M | ---- | 347.07%4.05M | ---- | 48.60%905K | ---- | -35.14%609K |
| Special items | ---- | -197.40%-3.45M | ---- | 122.81%3.54M | ---- | -23.53%-15.53M | ---- | -194.39%-12.58M | ---- | 201.70%13.32M |
| Operating profit before the change of operating capital | ---- | -270.29%-18.42M | ---- | 652.36%10.82M | ---- | -93.39%1.44M | ---- | 55.00%21.75M | ---- | -62.82%14.04M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | 89.33%53.89M | ---- | 266.44%28.46M | ---- | -77.76%-17.1M | ---- | -1,362.16%-9.62M | ---- | 99.42%-658K |
| Accounts payable increase (decrease) | ---- | 714.41%64.51M | ---- | -418.73%-10.5M | ---- | 94.92%-2.02M | ---- | -49.61%-39.83M | ---- | -126.06%-26.62M |
| Financial assets at fair value (increase)decrease | ---- | -26.40%6.66M | ---- | -55.04%9.05M | ---- | 363.92%20.12M | ---- | 61.78%-7.62M | ---- | 57.16%-19.95M |
| Financial liabilities at fair value (increase)decrease | ---- | --4.16M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items for working capital changes | ---- | -908.25%-78.02M | ---- | 163.13%9.65M | ---- | -156.74%-15.29M | ---- | 163.91%26.95M | ---- | -843.50%-42.17M |
| Cash from business operations | ---- | -30.98%32.78M | ---- | 469.32%47.48M | ---- | -53.55%-12.86M | ---- | 88.89%-8.37M | ---- | -216.24%-75.36M |
| Other taxs | ---- | 85.36%-319K | ---- | -144.01%-2.18M | ---- | 60.76%-893K | ---- | 76.12%-2.28M | ---- | -177.20%-9.53M |
| Dividend received - operating | ---- | -76.23%53K | ---- | 10.95%223K | ---- | -65.16%201K | ---- | -20.19%577K | ---- | --723K |
| Interest received - operating | ---- | 88.09%758K | ---- | -67.55%403K | ---- | -61.46%1.24M | ---- | 21.44%3.22M | ---- | --2.65M |
| Interest paid - operating | ---- | 24.12%-129K | ---- | 36.09%-170K | ---- | -7.26%-266K | ---- | 0.40%-248K | ---- | -4.18%-249K |
| Special items of business | 51.95%29.08M | ---- | -24.73%19.13M | ---- | 126.25%25.42M | ---- | 277.94%11.24M | ---- | 91.89%-6.31M | ---- |
| Net cash from operations | 51.95%29.08M | -27.58%33.14M | -24.73%19.13M | 463.95%45.76M | 126.25%25.42M | -77.16%-12.57M | 277.94%11.24M | 91.32%-7.1M | 91.89%-6.31M | -197.24%-81.76M |
| Cash flow from investment activities | ||||||||||
| Purchase of fixed assets | 71.97%-259K | 13.26%-1.17M | ---924K | ---1.35M | ---- | ---- | ---- | -276.09%-346K | ---339K | 87.77%-92K |
| Sale of subsidiaries | ---- | ---1.42M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---135K |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --540K | --540K | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -626.48%-3.92M | ---- | ---540K |
| Net cash from investment operations | 71.97%-259K | -91.56%-2.59M | ---924K | ---1.35M | ---- | ---- | ---- | -386.18%-3.73M | -94.52%201K | -131.08%-767K |
| Net cash before financing | 58.24%28.82M | -31.20%30.55M | -28.36%18.21M | 453.22%44.41M | 126.25%25.42M | -16.14%-12.57M | 283.79%11.24M | 86.88%-10.83M | 91.76%-6.11M | -229.60%-82.53M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | 100.50%50M | 133.33%35M | 398.76%24.94M | --15M | --5M |
| Refund | 99.61%-75K | -12,751.68%-19.15M | -25,677.03%-19.08M | 99.73%-149K | 99.82%-74K | ---55.15M | ---40.03M | ---- | ---- | ---- |
| Issuing shares | --33.89M | --390K | ---- | ---- | ---- | -88.06%696K | -86.21%696K | -69.42%5.83M | -31.49%5.05M | -85.92%19.06M |
| Interest paid - financing | 43.99%-666K | -22.93%-2.19M | -39.88%-1.19M | 52.94%-1.78M | 69.05%-850K | -475.34%-3.78M | -924.63%-2.75M | -92.67%-657K | 19.28%-268K | 51.29%-341K |
| Dividends paid - financing | ---- | ---- | ---- | ---10.15M | ---- | ---- | ---- | ---- | ---- | -23.19%-19.89M |
| Issuance expenses and redemption of securities expenses | 90.33%-650K | -34.34%-4.38M | ---6.72M | ---3.26M | ---- | ---- | ---- | -2.25%-4.68M | 21.65%-3.59M | 60.97%-4.58M |
| Net cash from financing operations | 209.78%31.01M | -32.12%-27.41M | -697.35%-28.24M | -54.58%-20.75M | 63.34%-3.54M | -167.91%-13.42M | -172.50%-9.66M | 372.96%19.76M | 164.61%13.33M | -107.19%-7.24M |
| Net Cash | 696.30%59.82M | -86.71%3.14M | -145.86%-10.03M | 191.04%23.67M | 1,291.67%21.88M | -390.88%-25.99M | -78.21%1.57M | 109.95%8.94M | 107.61%7.22M | -218.62%-89.77M |
| Begining period cash | 7.03%47.85M | 112.46%44.71M | 112.51%44.71M | -55.26%21.04M | -55.27%21.04M | 23.46%47.03M | 23.46%47.03M | -70.21%38.1M | -70.21%38.1M | 145.01%127.86M |
| Cash at the end | 210.51%107.67M | 7.03%47.85M | -19.20%34.68M | 112.51%44.71M | -11.70%42.92M | -55.27%21.04M | 7.27%48.6M | 23.46%47.03M | 37.21%45.31M | -70.21%38.1M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.